News · Press release

Compatible-pair design engagement framework: two-party consent structure published

← Back to Newsroom

For immediate release

Furnetics Unlimited Ltd. today announced that the Office of the General Counsel has published, as an annex to the Client Privacy Programme, a legal-and-clinical framework governing engagements in which two clients are designed together as a matched Morphic pair. The Compatible-Pair Design Engagement Framework, effective 1 July 2022, is offered as an elective structure for engagements under the Phenotype Renovations™ service line and provides a joint confidentiality trust, a joint consultation cadence, and a defined set of mutual medical-decision provisions between the two named principals. The framework takes no view on the clients' reasons for engaging jointly and does not require that any be stated.

Prior to today's publication, the corporation's private-client engagements have been structured, since January 2021, under the individual confidentiality trust described in the Client Privacy Programme — one instrument, one client, one design brief. Where two clients have previously wished to be designed together, the position has been that each engaged the corporation separately, under a separate trust, with any coordination between the two designs conducted informally between the clients themselves and their respective design counsellors. The Framework replaces that informal arrangement, at the clients' joint election, with a single instrument constituted at the level of the pair and administered as such throughout the engagement and the standard five-year structured follow-up that follows it.

“The Client Privacy Programme, as we published it in 2021, was written for the client in the singular. That is the ordinary case and will remain so. It is not, however, the only case, and the arrangements the corporation was reaching for by informal means when two clients came to us together have now grown to the point where an instrument is required. What is published today is that instrument. It does not ask why the two are here together; it presumes that the two, having said they are here together, know their own reasons, and it structures the corporation's response accordingly.”

— Priya Ravindran, General Counsel & Chief Privacy Officer

What the Framework provides

  • Joint confidentiality trust. A single trust instrument is constituted at the level of the pair, with both principals named as settlors and as beneficiaries in equal parts. The trust holds the design brief, the clinical record, and the follow-up record for both principals in a common file that neither may unilaterally disclose to a third party without the written concurrence of the other. All external disclosures — institutional, regulatory, or clinical — are counter-signed by both principals or by their respective attorneys under the powers described below.
  • Joint consultation cadence. The design consultation, ordinarily conducted as a series of one-to-one sessions between the client and the design counsellor, is instead conducted as an alternating series of joint and separate sessions, on a cadence set out in the Framework and modifiable by joint written election. The clinical consultation retains an individual-only session at each of the standard milestones, so that either principal may raise a matter with the clinician in the other's absence at any point.
  • Mutual medical-decision provisions. Each principal grants the other, as of right and under the trust, a limited durable healthcare power exercisable only during the peri-procedural window and only in respect of the Furnetics engagement. The power is bounded, revocable at any time by written notice, and expressly does not extend to any matter outside the scope of the joint engagement. Each principal may separately nominate an external attorney-in-fact to act alongside the other for the same purpose; the Framework provides the standard form for the appointment.
  • Symmetric exit. Either principal may withdraw from the joint engagement at any point before the procedural window opens, without penalty to either party and without any obligation to state a reason. On withdrawal, each principal is offered continuation under the individual confidentiality trust from which the joint trust was elected, with the joint record severed by counsel and returned to the two individual files under the Client Privacy Programme's standard practice.

What the Framework does not do

The Framework is not a domestic-partnership instrument, a status registration, or a certification of relationship of any kind between the two principals. It confers no rights on either principal beyond the four provisions set out above, expires with the completion of structured follow-up, and is not recognised as evidence of anything outside the corporation's own engagement. It does not require, permit, or discourage cohabitation, joint household, or shared residence at any stage. It does not condition either design on the other; each principal receives an individually specified Morphic design, subject to the ordinary design-consultation process, and coordination between the two briefs is at the joint election of the principals and their design counsellors. Where the two elect not to coordinate, the corporation does not press the point.

“Two clients arriving together are, first and always, two clients. The joint consultation is the corporation's acknowledgement that a design chosen alongside another is not the same design as one chosen alone — the questions the counsellor asks, the trade-offs the clinician surfaces, are different in kind — but the individual consultation at each milestone is our insistence that either client may still, at any moment, sit with us privately and speak their own mind. The Framework holds both of those things at once. It is our practice to hold them at once whether the instrument is signed or not; the instrument merely records the practice.”

— Dr. Kenji Arai, Chief Medical Officer

Entry conditions

Election of the joint framework is available at the intake stage of any Phenotype Renovations engagement in which both prospective clients have separately satisfied the corporation's ordinary intake requirements, including the age-of-majority requirement, the cooling-off period following first consultation, and the independent legal review of the confidentiality trust before signature. Each principal is required to obtain independent counsel for the review; the corporation maintains, and will provide to prospective clients, a panel of qualified reviewers in every jurisdiction from which Furnetics accepts referrals. Where any of the intake requirements is not satisfied by either principal, the joint framework is not available and the ordinary individual engagement continues to be offered.

The Framework is offered only under the Phenotype Renovations service line at the present time. The corporation does not, and will not under this Framework, engage two principals jointly under Genotype Renovations™, whose founder-cohort structure is defined at a different level and whose engagements remain governed by the Hephaestus Group's cohort-specific consent architecture. Nor does the Framework extend to Genetic Maintain™ or Genetic Select™, whose engagements are individual by their nature.

Consent architecture and the cooling-off period

The Framework's consent architecture layers the corporation's standard individual consent, the two principals' joint election of the framework, and the counter-signed durable healthcare powers into a single instrument executed in the presence of independent counsel for each principal. A thirty-day cooling-off period is written into the joint election, running from the date of joint execution and revocable by either principal within it without notice to the other's counsel. The peri-procedural window — during which the mutual medical-decision provisions become operative — opens no earlier than the end of the cooling-off period and closes at the completion of the fourth structured-follow-up interval.

The Framework document itself, together with the standard forms and the schedule of intake requirements, is available in redacted form on request from the Office of the General Counsel. The unredacted document is provided only to prospective principals and their independent counsel at the intake stage of a prospective joint engagement.

No change to safety register or Ethics Board oversight

The Framework is a structural instrument governing the form of engagement and does not alter the clinical or safety terms under which any Phenotype Renovations procedure is performed. Adverse-event surveillance continues to be conducted at the individual client level and reported under the existing safety register. The Independent Ethics Board reviewed the Framework in its March 2022 quarterly session and confirmed that its consent architecture is consistent with the Board's charter. The Framework does not open a new template class, a new procedure class, or any new adverse-event category.

Enquiries from institutional partners and regulators may be directed to the Office of the General Counsel, 15 Sükhbaatar Square, Ulaanbaatar. The corporation does not maintain a public register of joint engagements and will neither confirm nor deny that any particular pair is engaged under the Framework.

About Furnetics

Furnetics Unlimited Ltd. was founded in Cambridge in 1992 and has operated from its Ulaanbaatar campus since 2010. It offers four service lines — Genetic Maintain™, Phenotype Renovations™, Genotype Renovations™, and Genetic Select™ — under the oversight of an Independent Ethics Board constituted in 2014. Further information is available at furnetics.com.

— ends —